Balancing Innovation and Standards

The conversation dives into the complexities of navigating the rare disease market, emphasizing the importance of agility in drug development. Key insights highlight the need for a careful balance between establishing long-term standards and the necessity for rapid iteration and real-life case studies. Foundational product-market fit is crucial for startups to ensure sustainable growth and continued investment.